Evelo Biosciences Inc
NASDAQ:EVLO
Evelo Biosciences Inc
NASDAQ:EVLO
Price:
0.001 USD
-97.56%
Updated:
May 21, 2024
Evelo Biosciences Inc
Research & Development
|
Evelo Biosciences Inc
Research & Development Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Evelo Biosciences Inc
NASDAQ:EVLO
|
Research & Development
-$53.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$4.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
See Also
What is Evelo Biosciences Inc's Research & Development?
Research & Development
-53.5m
USD
-53.5m
USD
Based on the financial report for Sep 30, 2023, Evelo Biosciences Inc's Research & Development amounts to -53.5m USD.
What is Evelo Biosciences Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-9%
-9%
Over the last year, the Research & Development growth was 34%. The average annual Research & Development growth rates for Evelo Biosciences Inc have been 6% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
